Adial Pharmaceuticals, Inc.
ADILNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $14.51M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.32$8.75
- Volume (live)
- -
- Avg. volume (3M)
- 44.87K
Adial Pharmaceuticals (ADIL) Stock Price & Financial Analysis
Adial Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.07 - $3.66 |
|---|---|
| 52-Week High | $8.75 |
| 52-Week Low | $0.32 |
| Open | $3.07 |
| Volume (last close) | 56.44K |
| Average Volume (3M) | 44.87K |
| 50-Day MA | $4.86 |
|---|---|
| 200-Day MA | $3.34 |
| 1-Year Change | +772.46% |
| Market Cap | 14.51M |
|---|---|
| Shares Outstanding | 4.62M |
| Price to Book (P/B) | 93.03 |
| EV/EBITDA | 0.25 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Adial Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, Adial Pharmaceuticals (ADIL) has a market capitalization of $14.51M.
As of its latest reported balance sheet, it holds $28.71M in cash and securities against $0.00 of debt, a net cash position of $28.71M.
Adial Pharmaceuticals does not currently pay a dividend.
The share price is up 772.5% over the past year. At $3.49 (the Oct 16, 2026 close) it sits within its 52-week range of $0.32 to $8.75, above its 200-day moving average of $3.34.
Frequently Asked Questions About Adial Pharmaceuticals
What is the current stock price for ADIL?
As of the Oct 16, 2026 close, ADIL stock trades at $3.49. The 52-week range is $0.32–$8.75, with a day range of $3.07–$3.66.
What is the P/E ratio for ADIL?
The P/E ratio (Price-to-Earnings) for ADIL is shown in the Key Statistics section. This valuation metric helps compare Adial Pharmaceuticals, Inc. to industry peers.
Does ADIL pay dividends?
Adial Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ADIL?
Analyst ratings and recommendations for ADIL are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ADIL?
As of the Oct 16, 2026 close, Adial Pharmaceuticals's market capitalization is $16.1M, classifying it as a micro-cap company. Adial Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.